Caricamento...
Improving testing for hepatitis B before treatment with rituximab
AIMS/OBJECTIVES/BACKGROUND: Individuals with current or previous infection with the hepatitis B virus (HBV) can experience viral reactivation when treated with immunosuppression. Rituximab, an anti-CD20 antibody used to treat many diseases, has potent immunosuppressant effects with a high risk of ca...
Salvato in:
| Pubblicato in: | Eur J Gastroenterol Hepatol |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams And Wilkins
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5010281/ https://ncbi.nlm.nih.gov/pubmed/27388147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MEG.0000000000000689 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|